Lori M. Gawron, MD, MPH, FACOG

Journal Article

1. Gawron LM, Simmons RG, Sanders JN, Myers K, Gundlapalli AV, Turok D (2020). The effect of a no-cost contraceptive initiative on method selection by women with housing insecurity. Contraception, 101(3), 205-209.
2. Gawron LM, Sanders JN, Sward K, Poursaid AE, Simmons R, Turok D (2019). Multi-morbidity and Highly Effective Contraception in Reproductive-Age Women in the US Intermountain West: a Retrospective Cohort Study. Journal of general internal medicine, 35(3), 637-642.
3. Gawron LM, Pettey WBP, Redd AM, Suo Y, Turok DK, Gundlapalli A (2019). Distance Matters: Geographic barriers to long acting reversible and permanent contraception for homeless women Veterans. Journal of social distress and the homeless, 28(2), 139-148.
4. Sanders JN, Myers K, Gawron LM, Simmons RG, Turok D (2018). Contraceptive Method Use During the Community-Wide HER Salt Lake Contraceptive Initiative. American journal of public health, 108(4), 550-556.
5. Sanders JN, Higgins JA, Adkins DE, Stoddard GJ, Gawron LM, Turok D (2018). The Impact of Sexual Satisfaction, Functioning, and Perceived Contraceptive Effects on Sex Life on IUD and Implant Continuation at 1 Year. Women's health issues, 28(5), 401-407.
6. Gawron LM, Mohanty AF, Kaiser JE, Gundlapalli A (2018). Impact of Deployment on Reproductive Health in U.S. Active-Duty Servicewomen and Veterans. Seminars in reproductive medicine, 36(6), 361-370.
7. Sanders JN, Adkins DE, Kaur S, Storck K, Gawron LM, Turok D (2018). Bleeding, cramping, and satisfaction among new copper IUD users: A prospective study. PloS one, 13(11), e0199724.
8. Turok DK, Simmons RG, Cappiello B, Gawron LM, Saviers-Steiger J, Sanders J (2018). Use of a novel suction cervical retractor for intrauterine device insertion: a pilot feasibility trial. BMJ sexual & reproductive health,
9. Turok DK, Leeman L, Sanders JN, Thaxton L, Eggebroten JL, Yonke N, Bullock H, Singh R, Gawron LM, Espey (2017). Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial. American journal of obstetrics and gynecology, 217(6), 665.e1-665.e8.
10. Sanders JN, Turok DK, Royer PA, Thompson IS, Gawron LM, Storck K (2017). One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception. Contraception, 96(2), 99-105.
11. Gawron LM, Redd A, Suo Y, Pettey W, Turok DK, Gundlapalli A (2017). Long-acting Reversible Contraception Among Homeless Women Veterans With Chronic Health Conditions: A Retrospective Cohort Study. Medical care, 55 Suppl 9 Suppl 2, S111-S120.
12. Sanders JN, Gawron LM, Friedman (2016). Sexual satisfaction and inflammatory bowel diseases: an interdisciplinary clinical challenge. American journal of obstetrics and gynecology, 215(1), 58-62.
13. Gawron LM, Gawron AJ, Kasper A, Hammond C, Keefer (2014). Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey. Contraception, 89(5), 419-25.
14. Gawron LM, Hammond C, Keefer (2014). Documentation of reproductive health counseling and contraception in women with inflammatory bowel diseases. Patient education and counseling, 94(1), 134-7.
15. Gawron LM, Goldberger A, Gawron AJ, Hammond C, Keefer (2014). The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases. Inflammatory bowel diseases, 20(10), 1729-33.
16. Gawron LM, Hammond C, Ernst L (2013). Perinatal pathologic examination of nonintact, second-trimester fetal demise specimens: the value of standardization. Archives of pathology & laboratory medicine, 137(8), 1083-7.
17. Mody SK, Kiley J, Gawron L, Garcia P, Hammond (2013). Team-based learning: a novel approach to medical student education in family planning. Contraception, 88(2), 239-42.
18. Gawron LM, Cameron KA, Phisuthikul A, Simon M (2013). An exploration of women's reasons for termination timing in the setting of fetal abnormalities. Contraception, 88(1), 109-15.
19. Gawron LM, Kiley J (2013). Labor induction outcomes in third-trimester stillbirths. International journal of gynaecology and obstetrics, 123(3), 203-6.
20. Mody SK, Kiley J, Rademaker A, Gawron L, Stika C, Hammond (2012). Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block. Contraception, 86(6), 704-9.

Review

1. Ernst LM, Gawron L, Fritsch M (2013). Pathologic examination of fetal and placental tissue obtained by dilation and evacuation. Archives of pathology & laboratory medicine, 137(3), 326-37.

Case Report

1. Gawron LM, Goldman KN, Kiley J (2013). A gravid development: should the desire to maintain fertility determine treatment for profuse bleeding in pregnancy? Am J Obstet Gynecol, 208(4), 332.e1-2.

Letter

1. Gawron LM, Gero A, Kushner KL, Turok DK, Sanders J (2019). Unprotected intercourse in the 2 weeks prior to quick-start initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception. American journal of obstetrics and gynecology, 222(4S), S891-S892.

Abstract

1. Gawron LM, Goldberger AR, Gawron AJ, Hammond C, Keefer (2014). The Effect of Hormonal Contraceptives on Menstrual-Related Inflammatory Bowel Disease Symptoms. 146(5), S-552.
2. Kasper A, Keefer L, Gawron AJ, Gossett, DR, Hahn EA, Gawron L (2014). Fertility-Related Knowledge in Women with Inflammatory Bowel Disease. 146(5), S-370.
3. Gawron LM, Goldberger AR, Gawron AJ, Hammond C, Keefer (2014). Disease-related Pregnancy Concerns and Reproductive Planning in Women with Inflammatory Bowel Disease. 146(5), S-195.
4. Gawron LM, Hammond C, Keefer (2013). Documentation of reproductive health counseling and contraception in women with inflammatory bowel disease. 155(5), S-198.

News

• Hormonal IUDs Are a Viable and Underutilized Method for Emergency Contraception